Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) is technically a diabetes medication, but multiple clinical trials have documented significant weight loss as a secondary benefit. The drug works by activating GLP-1 receptors in the brain and gut, signaling fullness and reducing calorie intake. Understanding how this mechanism functions helps explain why it has become a tool for weight management beyond diabetes care.
How Does Ozempic Promote Weight Loss?
Semaglutide, the active ingredient in Ozempic, mimics glucagon-like peptide-1 (GLP-1), a natural hormone that regulates blood sugar and appetite. When injected weekly, it binds to GLP-1 receptors throughout the brain, particularly in areas controlling hunger and satiety. This binding creates a sustained sense of fullness, reducing overall food intake without requiring extreme dietary restriction.
The medication also slows gastric emptying—the rate at which food moves from your stomach to your small intestine. This delayed digestion extends feelings of satisfaction after meals and stabilizes blood sugar levels, reducing the energy crashes that often trigger cravings. Clinical data shows these combined effects produce weight loss independent of diabetes status, making semaglutide effective for individuals without type 2 diabetes who struggle with weight management.
Clinical Evidence: Weight Loss Outcomes With Semaglutide
The STEP trials, which specifically examined semaglutide for weight management, enrolled thousands of adults with overweight or obesity. Participants receiving 2.4 mg weekly injections lost approximately 15% of their baseline body weight over 68 weeks, compared to roughly 2.7% in the placebo group. These results were consistent across diverse age groups, ethnicities, and metabolic profiles, establishing semaglutide as a clinically validated tool for weight reduction.
Beyond the STEP program, real-world data from patients using semaglutide for weight loss show sustained outcomes when treatment continues. Weight regain typically occurs after discontinuation, suggesting ongoing therapy maintains the benefits of appetite suppression and metabolic improvement. Combining injection therapy with behavioral support—dietary counseling, activity increases, and stress management—amplifies results and improves long-term adherence.
Key Differences Between Ozempic and Compounded Semaglutide
Ozempic is a brand-name product distributed through traditional pharmaceutical channels and typically requires insurance or significant out-of-pocket spending. PlexusDx offers compounded semaglutide injections prepared by licensed 503A compounding pharmacies, delivered directly to patients without insurance requirements. Compounded formulations follow FDA manufacturing standards for strength, purity, and sterility, ensuring clinical-grade quality at a fraction of retail brand pricing.
PlexusDx compounded semaglutide starts at $149 per month across a flexible commitment tier system, with your dose adjusted as needed—but your price remains stable. Oral semaglutide tablets are also available starting at $249 monthly for patients who prefer non-injection delivery. All medications ship to all 50 states, and both HSA and FSA accounts can cover the cost, making personalized weight loss therapy accessible regardless of insurance status.
Genetic Factors That Influence Semaglutide Response
Not everyone responds to semaglutide identically; genetic variations in GLP-1 and other weight-regulation pathways affect how effectively the medication works for individual patients. The GLP1R gene variant rs6923761 influences receptor sensitivity, while the FTO variant rs9939609 modulates appetite signaling and metabolic rate. PlexusDx Precision Peptide Genetic Test maps 14 distinct pathways across 49 peptides to identify genetic predispositions affecting weight loss drug response.
Understanding your genetic profile allows clinicians to predict whether semaglutide alone will be optimal or whether a dual-compound approach—like GLP-Squared, combining semaglutide with tirzepatide—may yield better outcomes. The Precision Peptide test costs $99 as an add-on after your first month of treatment and provides actionable insights into your individual peptide biology. This personalization removes guesswork from treatment selection and increases the likelihood of achieving your weight loss goals.
Side Effects and Safety Considerations With Semaglutide
Common side effects of semaglutide include nausea, vomiting, constipation, and diarrhea, particularly during the first weeks of treatment or dose escalation. These gastrointestinal effects typically diminish as your body adapts, and they occur less frequently with oral formulations than with injections. Serious but rare complications include pancreatitis and gallbladder issues; patients with a personal or family history of medullary thyroid cancer should not use GLP-1 medications.
PlexusDx treatment includes medical oversight to monitor side effects and adjust therapy as needed. Starting with lower doses and escalating gradually minimizes nausea and other tolerability issues. Your healthcare provider reviews your progress monthly and can switch you to an alternative compound or oral formulation if injection-based therapy causes persistent discomfort.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic approved by the FDA for weight loss in people without diabetes?
Ozempic itself carries a diabetes indication, but the active ingredient semaglutide has an FDA-approved weight-loss formulation called Wegovy for adults with obesity or overweight with weight-related conditions. PlexusDx compounded semaglutide is not FDA-approved but is manufactured to pharmaceutical standards by licensed 503A compounding pharmacies and prescribed off-label under medical supervision for weight management.
How much weight can I expect to lose with semaglutide injections?
Clinical trials show average weight loss of 15% over 68 weeks with weekly 2.4 mg semaglutide injections, though individual results vary. Genetic factors, diet consistency, exercise, and stress management significantly influence outcomes. PlexusDx offers the optional Precision Peptide Genetic Test to identify your genetic predispositions and predict your likely response profile.
What is the cost of PlexusDx semaglutide compared to brand-name Ozempic?
PlexusDx compounded semaglutide injections start at $149 per month with stable pricing across commitment tiers—your dose may increase, but your price won't. No insurance is required, and both HSA and FSA accounts are eligible. Brand-name Ozempic or Wegovy typically cost hundreds of dollars monthly out-of-pocket or require insurance coverage.
Are there differences in effectiveness between injection and oral semaglutide?
Injection semaglutide is absorbed directly into the bloodstream and generally produces faster, more predictable appetite suppression. Oral semaglutide (tablets) works through intestinal absorption and may be gentler on the stomach for some patients but typically requires higher doses for equivalent effect. PlexusDx offers both forms; your doctor will recommend the best option based on your tolerance and goals.
Can the Precision Peptide Genetic Test predict whether semaglutide will work for me?
Yes. PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 other weight-regulation pathways across 49 peptides. Key variants like GLP1R rs6923761 directly influence your receptor sensitivity to semaglutide, helping your clinician determine if semaglutide alone or a dual-compound protocol (GLP-Squared) will optimize your results. The test costs $99 and is available after your first treatment month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Journey: Why Increasing Your Wegovy Dose is Key for Lasting Weight Loss
How Successful is Wegovy for Weight Loss: An In-Depth Look at Results and Considerations